154 related articles for article (PubMed ID: 35545664)
1. Unique and joint associations of polygenic risk for major depression and opioid use disorder with endogenous opioid system function.
Love T; Shabalin AA; Kember RL; Docherty AR; Zhou H; Koppelmans V; Gelernter J; Baker AK; Hartwell E; Dubroff J; Zubieta JK; Kranzler HR
Neuropsychopharmacology; 2022 Sep; 47(10):1784-1790. PubMed ID: 35545664
[TBL] [Abstract][Full Text] [Related]
2. Associations between major psychiatric disorder polygenic risk scores and blood-based markers in UK biobank.
Sewell MDE; Jiménez-Sánchez L; Shen X; Edmondson-Stait AJ; Green C; Adams MJ; Rifai OM; McIntosh AM; Lyall DM; Whalley HC; Lawrie SM
Brain Behav Immun; 2021 Oct; 97():32-41. PubMed ID: 34107350
[TBL] [Abstract][Full Text] [Related]
3. Sex-specific association between infant caudate volumes and a polygenic risk score for major depressive disorder.
Acosta H; Kantojärvi K; Tuulari JJ; Lewis JD; Hashempour N; Scheinin NM; Lehtola SJ; Fonov VS; Collins DL; Evans A; Parkkola R; Lähdesmäki T; Saunavaara J; Merisaari H; Karlsson L; Paunio T; Karlsson H
J Neurosci Res; 2020 Dec; 98(12):2529-2540. PubMed ID: 32901998
[TBL] [Abstract][Full Text] [Related]
4. Polygenic risk for depression and the neural correlates of working memory in healthy subjects.
Yüksel D; Dietsche B; Forstner AJ; Witt SH; Maier R; Rietschel M; Konrad C; Nöthen MM; Dannlowski U; Baune BT; Kircher T; Krug A
Prog Neuropsychopharmacol Biol Psychiatry; 2017 Oct; 79(Pt B):67-76. PubMed ID: 28624581
[TBL] [Abstract][Full Text] [Related]
5. Polygenic interactions with environmental adversity in the aetiology of major depressive disorder.
Mullins N; Power RA; Fisher HL; Hanscombe KB; Euesden J; Iniesta R; Levinson DF; Weissman MM; Potash JB; Shi J; Uher R; Cohen-Woods S; Rivera M; Jones L; Jones I; Craddock N; Owen MJ; Korszun A; Craig IW; Farmer AE; McGuffin P; Breen G; Lewis CM
Psychol Med; 2016 Mar; 46(4):759-70. PubMed ID: 26526099
[TBL] [Abstract][Full Text] [Related]
6. Dysregulation of endogenous opioid emotion regulation circuitry in major depression in women.
Kennedy SE; Koeppe RA; Young EA; Zubieta JK
Arch Gen Psychiatry; 2006 Nov; 63(11):1199-208. PubMed ID: 17088500
[TBL] [Abstract][Full Text] [Related]
7. Polygenic risk for immuno-metabolic markers and specific depressive symptoms: A multi-sample network analysis study.
Kappelmann N; Czamara D; Rost N; Moser S; Schmoll V; Trastulla L; Stochl J; Lucae S; ; Binder EB; Khandaker GM; Arloth J
Brain Behav Immun; 2021 Jul; 95():256-268. PubMed ID: 33794315
[TBL] [Abstract][Full Text] [Related]
8. Association Between Placebo-Activated Neural Systems and Antidepressant Responses: Neurochemistry of Placebo Effects in Major Depression.
Peciña M; Bohnert AS; Sikora M; Avery ET; Langenecker SA; Mickey BJ; Zubieta JK
JAMA Psychiatry; 2015 Nov; 72(11):1087-94. PubMed ID: 26421634
[TBL] [Abstract][Full Text] [Related]
9. Genetic liability for substance use associated with medical comorbidities in electronic health records of African- and European-ancestry individuals.
Hartwell EE; Merikangas AK; Verma SS; Ritchie MD; ; Kranzler HR; Kember RL
Addict Biol; 2022 Jan; 27(1):e13099. PubMed ID: 34611967
[TBL] [Abstract][Full Text] [Related]
10. Polygenic Risk Scores Derived From Varying Definitions of Depression and Risk of Depression.
Mitchell BL; Thorp JG; Wu Y; Campos AI; Nyholt DR; Gordon SD; Whiteman DC; Olsen CM; Hickie IB; Martin NG; Medland SE; Wray NR; Byrne EM
JAMA Psychiatry; 2021 Oct; 78(10):1152-1160. PubMed ID: 34379077
[TBL] [Abstract][Full Text] [Related]
11. Polygenic risk for depression, anxiety and neuroticism are associated with the severity and rate of change in depressive symptoms across adolescence.
Kwong ASF; Morris TT; Pearson RM; Timpson NJ; Rice F; Stergiakouli E; Tilling K
J Child Psychol Psychiatry; 2021 Dec; 62(12):1462-1474. PubMed ID: 33778956
[TBL] [Abstract][Full Text] [Related]
12. Blunted Endogenous Opioid Release Following an Oral Amphetamine Challenge in Pathological Gamblers.
Mick I; Myers J; Ramos AC; Stokes PR; Erritzoe D; Colasanti A; Gunn RN; Rabiner EA; Searle GE; Waldman AD; Parkin MC; Brailsford AD; Galduróz JC; Bowden-Jones H; Clark L; Nutt DJ; Lingford-Hughes AR
Neuropsychopharmacology; 2016 Jun; 41(7):1742-50. PubMed ID: 26552847
[TBL] [Abstract][Full Text] [Related]
13. Associations of polygenic risks, depression, and obesity-related traits in Taiwan Biobank.
Liao SF; Su CY; Su MH; Chen CY; Chen CY; Lin YF; Pan YJ; Hsiao PC; Chen PC; Huang YT; Wu CS; Wang SH
J Affect Disord; 2023 Jan; 320():397-403. PubMed ID: 36206878
[TBL] [Abstract][Full Text] [Related]
14. Relationship between mood disorders and substance involvement and the shared genetic liabilities: A population-based study in Taiwan.
Lai RY; Su MH; Lin YF; Chen CY; Pan YJ; Hsiao PC; Chen PC; Huang YT; Wu CS; Wang SH
J Affect Disord; 2024 Jan; 345():168-176. PubMed ID: 37879417
[TBL] [Abstract][Full Text] [Related]
15. Polygenic risk for severe psychopathology among Europeans is associated with major depressive disorder in Han Chinese women.
Edwards AC; Docherty AR; Moscati A; Bigdeli TB; Peterson RE; Webb BT; Bacanu SA; Hettema JM; Flint J; Kendler KS
Psychol Med; 2018 Apr; 48(5):777-789. PubMed ID: 28969721
[TBL] [Abstract][Full Text] [Related]
16. Nicotine-specific and non-specific effects of cigarette smoking on endogenous opioid mechanisms.
Nuechterlein EB; Ni L; Domino EF; Zubieta JK
Prog Neuropsychopharmacol Biol Psychiatry; 2016 Aug; 69():69-77. PubMed ID: 27095017
[TBL] [Abstract][Full Text] [Related]
17. Interplay between polygenic risk for mood disorders and stressful life events in bipolar disorder.
Hosang GM; Shakoor S; King N; Sanches M; Vincent JB; Kennedy JL; McGuffin P; Keers R; Zai CC
J Affect Disord; 2024 Apr; 350():565-572. PubMed ID: 38246285
[TBL] [Abstract][Full Text] [Related]
18. Gender differences in the associations of multiple psychiatric and chronic conditions with major depressive disorder among patients with opioid use disorder.
Nwabueze C; Elom H; Liu S; Walter SM; Sha Z; Acevedo P; Liu Y; Su BB; Xu C; Piamjariyakul U; Wang K
J Addict Dis; 2022; 40(2):168-178. PubMed ID: 34328394
[TBL] [Abstract][Full Text] [Related]
19. Genetic and non-genetic predictors of risk for opioid dependence.
Na PJ; Deak JD; Kranzler HR; Pietrzak RH; Gelernter J
Psychol Med; 2024 Jun; 54(8):1779-1786. PubMed ID: 38317430
[TBL] [Abstract][Full Text] [Related]
20. Genomic prediction of depression risk and resilience under stress.
Fang Y; Scott L; Song P; Burmeister M; Sen S
Nat Hum Behav; 2020 Jan; 4(1):111-118. PubMed ID: 31659322
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
